Association of Low and Intermediate Combined Positive Scores With Outcomes of Treatment With Pembrolizumab in Patients With Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Authors :: Yao, Yu
Kaveh, Zakeri
Eric J, Sherman
Nancy Y, Lee
Source :: JAMA Oncol
Publication Year :: 2022
Publisher :: American Medical Association (AMA), 2022.
Abstract: This secondary analysis of the Keynote 048 trial examines treatment with pembrolizumab in patients with recurrent and metastatic head and neck squamous cell carcinoma.

Subjects :: Cancer Research
Treatment Outcome
Oncology
Head and Neck Neoplasms
Squamous Cell Carcinoma of Head and Neck
Research Letter
Humans
Neoplasm Recurrence, Local
Antibodies, Monoclonal, Humanized

Tools